IMI’s Mofina project has developed a portable device which can test for deadly Ebola in 75 minutes or less, eliminating the need to take suspected Ebola patients to treatment centres far away of their communities. In an interview, the project coordinator explains how Mofina’s success will save lives, and help contain future outbreaks.
IMI’s RADAR-CNS project has recruited the first participants in the depression component of its study. RADAR-CNS aims to develop new ways of measuring major depressive disorder, epilepsy and multiple sclerosis using wearable devices and smartphone technology. The first study participants have received FitBit Charge 2 devices and smartphone apps.